GKB Ophthalmics Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Consistent revenue growth observed over the last four quarters, indicating strong demand for ophthalmic products.
Improvement in gross margins suggests effective cost management and pricing strategies in a competitive market.
Strong cash flow generation enables reinvestment in R&D and innovation for long-term growth.

NEGATIVES

Declining net profit margin reflects increasing operational costs and potential pricing pressures in the manufacturing sector.
Higher debt levels compared to previous quarters may limit financial flexibility for future expansions.
Market volatility and supply chain disruptions could impact production schedules and profitability going forward.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Jun 25
Revenue	22.26	20.40	24.04	21.56	26.02	26.14	25.80	32.30
Expenses	22.05	21.89	25.70	22.84	26.29	27.52	28.12	33.06
Operating Profit	0.21	-1.49	-1.66	-1.28	-0.27	-1.38	-2.31	-0.76
Other Income	0.35	0.31	0.35	0.50	0.28	0.23	0.48	0.21
Interest	0.43	0.45	0.44	0.57	0.55	0.55	0.64	0.77
Depreciation	0.72	0.73	0.73	0.72	0.76	0.77	0.77	0.80
Profit Before Tax	0.55	-1.19	-1.44	-0.69	0.16	-1.09	-1.86	-0.56
Tax	0	0	0	0.20	0.06	0.06	0.05	0.08
Net Profit	0.54	-1.19	-1.44	-0.89	0.11	-1.15	-1.91	-0.64
Eps in Rs	1.04	-2.32	-2.48	-1.81	-0.50	-2.41	-4.03	-2.02